Strategic Information for the Life Science and Analytical Instrument Industry
Before the US tariff policy changes enacted by the White House in April 2025, investors saw dividends as a stable source of income. In December 2024, according to the Wall Street Journal (WSJ), analysts forecast that dividend paying companies would be a stable investment because of uncertain sentiment around the US economy and stock market, […]
In 2025, the analytical and life science instrumentation industry weathered challenges such as funding constraints in the early-stage biotech and US academic and government sectors, as well as changes in tariff policies. Nonetheless, Strategic Directions International (SDi) predicts in its 2026 “Global Assessment Report” that the industry will overcome these obstacles by meeting demand in […]
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
Share repurchase programs have been a heavily discussed topic among investors and analysts, with some questioning their relationship to a company’s financial health. Among the leading reasons companies initiate share repurchase programs is to reduce the number of outstanding shares, thereby increasing the value of the remaining shares. Additionally, companies buy back shares to demonstrate […]
In the past few years, select governments around the world have emphasized the societal importance of clean water by passing legislation for safer drinking water and combating climate change and other environmental hazards. Water testing is one of the many avenues that scientists and others utilize to monitor water safety and pollution. Laboratories could not […]
10x Genomics (10x) is a US-based life science technology company that manufactures genomic and cell analysis technology for scientific research applications. Specifically, the firm’s products and offerings cater to end-users conducting bulk, single-cell and spatial biology analyses. Due to being part of the research scientific tools market, 10x’s co-founder and CEO Serge Saxonov, Ph.D., presented […]
The advent of the COVID-19 pandemic in 2020 highlighted the importance of the pharmaceutical and biopharmaceutical sectors as scientists worked tirelessly utilizing analytical and scientific instruments to create vaccines to combat the virus. Now that the pandemic has subsided, both the pharma and biotech markets are struggling with issues such as lack of funding for […]
According to KPMG’s CEO Outlook reports between 2021 and 2023, M&A was a crucial growth strategy for executives. Specifically, CEOs believed M&A deals were a way to drive sales growth for companies and moderate external factors such as potential emerging technology disruptions, regulatory demands, and geopolitical and macroeconomic concerns. Additionally, executives who participated in the […]
One can look at the inventions of the semiconductor and the battery to show why the industrial end-market plays a pivotal role in advancing technology. However, manufacturers of semiconductors, batteries, chemical products, plastics and other products would be unable to make advancements without the assistance of analytical technologies. Due to its importance to society and […]
Despite macroeconomic and industry-related challenges, Europe has been a steady regional market for the analytical and scientific instrument industry. IBO’s publisher, Strategic Directions International (SDi), part of Science and Medicine Group, believes market growth in Europe will occur for various reasons. For example, the EU’s scientific research funding program, Horizon Europe, has led to demand […]
